Resources

Type of publications
Regions
Diseases

5255 results found

2024 ∙ Shah, S. Dahal, K. Thapa, S. Subedi, P. Paudel, B. S. Chand, S. Salem, A. Lammle, M. Sah, R. Krsak, M.

Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Asante, M. A. Michelsen, M. E. Balakumar, M. M. Kumburegama, B. Sharifan, A. Thomsen, A. R. Korang, S. K. Gluud, C. Menon, S.

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Alpeza, F. Avermark, H. Gobbo, E. Herzig van Wees, S.

How has co-design been used to address vaccine hesitancy globally? A systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Herieka, H. Babalis, D. Tzala, E. Budhathoki, S. Johnson, N. A.

How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities

  • Europe
  • United Kingdom
  • All age groups
  • COVID-19
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Li, C. Zhang, M. Karthijekan, K. Fu, X.

How nurses contribute to the elimination of hepatitis B? A systematic review and meta-analysis

  • Healthcare workers
  • Hepatitis B
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Isonne, C. Iera, J. Sciurti, A. Renzi, E. De Blasiis, M. R. Marzuillo, C. Villari, P. Baccolini, V.

How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Asgedom, Y. S. Kebede, T. M. Seifu, B. L. Mare, K. U. Asmare, Z. A. Asebe, H. A. Kase, B. F. Shibeshi, A. H. Tebeje, T. M. Sabo, K. G. Fente, B. M. Lombebo, A. A. Koyira, M. M. Kassie, G. A.

Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis

  • Africa
  • Adolescents
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Motamed, H. Yari, F. Javadirad, E. Golmohammadi, S. Alimoradi, S. Naleini, R. Chegene Lorestani, R. Nemati Zargaran, F. Rostamian, M.

Human vaccine candidates for infections caused by Klebsiella pneumoniae: A systematic review

  • All age groups
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, X. Z. Li, Y. W. Huang, C. Y. Liu, J. L. Liu, R. B. Zhang, Z. X. Yan, J. Z. Zhang, C.

Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ferrara, P. Losa, L. Mantovani, L. G. Ambrosioni, J. Aguero, F.

Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression

  • Newborn
  • Children
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...